4//SEC Filing
CLARKE JOHN K 4
Accession 0001209191-20-027949
CIK 0001339970other
Filed
May 7, 8:00 PM ET
Accepted
May 8, 4:48 PM ET
Size
5.4 KB
Accession
0001209191-20-027949
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
CLARKE JOHN K
DirectorOther
Transactions
- Award
Stock Option (right to buy)
2020-05-06+1,428→ 1,428 totalExercise: $3.65Exp: 2030-05-06→ Common Stock (1,428 underlying)
Footnotes (1)
- [F1]The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 6, 2021 or (ii) the Issuer's 2021 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.
Documents
Issuer
aTYR PHARMA INC
CIK 0001339970
Entity typeother
Related Parties
1- filerCIK 0001219015
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 4:48 PM ET
- Size
- 5.4 KB